The PED ShopStore Guide Shop
Home / By goal / Strength and Power

Strength and Power: A Different Question from Size

Strength expression and muscle cross-section are related but not the same, and the compounds that serve them differ.

Strength gains come from neural adaptation and connective-tissue capacity as well as from muscle cross-section. Compounds associated with strength disproportionately to size tend to be high-affinity androgens, and this is where the most androgenic compounds in the range cluster.

That clustering is not incidental. High androgen-receptor binding affinity is associated with both the strength effect and the side-effect profile, and the two are not separable because they proceed from the same receptor interaction.

Several compounds in this group carry a notably high hepatic burden, which is why they appear in the literature with the shortest exposure durations of any category.

What to weigh up

The strongest compounds have the narrowest margins

The compounds most associated with strength are also those with the highest hepatic and cardiovascular considerations.

Connective tissue lags

Strength can outpace tendon and ligament adaptation. This is a documented injury mechanism, not a theoretical one.

Blood pressure is the marker to watch

Several compounds in this group raise blood pressure markedly. It is the most commonly cited reason for discontinuation.

Duration is the lever

Across this category the literature is consistent that exposure duration, not amount, drives the risk profile.

Stocked for this goal

22 products, 16 in stock

Go deeper

This page covers what serves the goal. For what each compound actually is - class, mechanism, half-life and storage - see the reference library.

Compound referenceClass, mechanism, pharmacokinetics and storageFirst order checklistWhat to get right before you buy